共 129 条
[1]
Vasen HFA(1998)Current policies for surveillance and management in women at risk of breast and ovarian cancer: a survey among 16 european family cancer clinics Eur J Cancer 34 1922-1926
[2]
Haites NE(2001)Effectiveness of breast cancer surveillance in BRCA1/2 gene mutation carriers and women with high familial risk J Clin Oncol 19 924-930
[3]
Evans DGR(2002)Outcome of preventive surgery and screening for breast and ovarian cancer in BRCA mutation carriers J Clin Oncol 20 1260-1268
[4]
Brekelmans CT(2004)The development of interval breast malignancies in patients with BRCA mutations Cancer 100 2079-2083
[5]
Seynaeve C(2001)MRI screening for breast cancer in women with familial or genetic predisposition: design of the Dutch national study (MRISC) Fam Cancer 1 163-168
[6]
Bartels CC(2004)Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition N Engl J Med 351 427-437
[7]
Scheuer L(2004)Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination JAMA 292 1317-1325
[8]
Kauff N(2005)Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS) Lancet 365 1769-1778
[9]
Robson M(2005)Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer J Clin Oncol 23 8469-8476
[10]
Komenaka IK(1999)The effect of hormone replacement therapy on the sensitivity of screening mammograms Clin Radiol 54 285-288